Publication | Open Access

A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC

OncologyCurrent ProgressMedicinePathologySalivary GlandsPhase Ii StudyMolecular OncologyAnti-cancer AgentTumor TargetingCancer TreatmentPharmacologyRadiation OncologyCancer ResearchEndocrine-related Cancer